N04.5
Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis
Clinical Classification Guidelines
Excludes Type 1
- Nephrotic syndrome with C3 glomerulonephritis (N04.A)
- Nephrotic syndrome with C3 glomerulopathy (N04.A)
Medical Intelligence & Overview
Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis, classified under ICD-10 code N04.5, is a kidney disorder characterized by significant protein loss in the urine, swelling, and damage to the glomeruli—tiny filtering units within the kidneys. This condition involves a particular type of glomerulonephritis that affects the mesangial and capillary areas of the glomeruli, leading to impaired kidney function and the hallmark features of nephrotic syndrome.
Causes & Symptoms
Clinical Causes: Autoimmune responses where the body's immune system attacks kidney tissues Infections, such as hepatitis B, hepatitis C, or endocarditis Certain genetic disorders or hereditary conditions Exposure to toxins or drugs that can damage kidney tissue Underlying diseases like lupus erythematosus Idiopathic cases where no specific cause can be identified
Key Symptoms: Swelling (edema), particularly around the eyes, ankles, and abdomen Foamy urine due to high protein content Weight gain from fluid retention Fatigue and weakness High blood pressure Loss of appetite and nausea Reduced urine output in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and laboratory tests. Key diagnostics include:
Treatment Protocols: Managing this condition often requires a comprehensive approach aimed at controlling symptoms, reducing kidney damage, and addressing underlying causes. Common strategies include:
Clinical Advice & FAQs
Billing Guidance
Is N04.5 a billable ICD-10 code?
Yes, N04.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.5?
Clinical documentation must specify the nature of Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference